26 Jun 2017 | Leafly
An Israeli company will partner with an Australian one to help boost clinical education opportunities around medical cannabis.
26 Jun 2017 | Fin Feed
Diversified investment company focused on high-growth market segments, Chapmans (ASX: CHP) announced on Friday that its specialist wholly owned medicinal cannabis subsidiary, Cannabis Investments Limited (CIL), had entered into a Term Sheet with AZ Pharmaceuticals Inc.
22 Jun 2017 | Stock News Now
Cannabis Science, Inc., a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that its new product-development plans are well underway with the release of the first batch of the CBIS Transdermal Patch.